Clive A. Meanwell founded The Medicines Co. Presently, Dr. Meanwell is Chief Executive Officer of Rempex Pharmaceuticals, Inc. Chief Innovation Officer at The Medicines Co. which he founded. Dr. Meanwell is also on the board of BB Biotech AG and Pharmaceutical Research & Manufacturers of America.
He previously held the position of Managing Director & Partner at Mpm Capital LLC, President at Targanta Therapeutics Corp. and Senior Vice President of Hoffmann-La Roche, Inc.
Clive A. Meanwell received a doctorate from the University of Birmingham.